» Articles » PMID: 35146973

Effects of Patient-specific Treatment Planning on Eligibility for Photodynamic Therapy of Deep Tissue Abscess Cavities: Retrospective Monte Carlo Simulation Study

Overview
Journal J Biomed Opt
Date 2022 Feb 11
PMID 35146973
Authors
Affiliations
Soon will be listed here.
Abstract

Significance: Antimicrobial photodynamic therapy (PDT) effectively kills bacterial strains found in deep tissue abscess cavities. PDT response hinges on multiple factors, including light dose, which depends on patient optical properties.

Aim: Computed tomography images for 60 abscess drainage subjects were segmented and used for Monte Carlo (MC) simulation. We evaluated effects of optical properties and abscess morphology on PDT eligibility and generated treatment plans.

Approach: A range of abscess wall absorptions (μa  ,  wall) and intra-cavity Intralipid concentrations were simulated. At each combination, the threshold optical power and optimal Intralipid concentration were found for a fluence rate target, with subjects being eligible for PDT if the target was attainable with <2000  mW of source light. Further simulations were performed with absorption within the cavity (μa  ,  cavity).

Results: Patient-specific treatment planning substantially increased the number of subjects expected to achieve an efficacious light dose for antimicrobial PDT, especially with Intralipid modification. The threshold optical power and optimal Intralipid concentration increased with increasing μa  ,  wall (p  <  0.001). PDT eligibility improved with patient-specific treatment planning (p  <  0.0001). With μa  ,  wall  =  0.2  cm  -  1, eligibility increased from 42% to 92%. Increasing μa  ,  cavity reduced PDT eligibility (p  <  0.0001); modifying the delivered optical power had the greatest impact in this case.

Conclusions: MC-based treatment planning greatly increases eligibility for PDT of abscess cavities.

Citing Articles

Devices and Methods for Dosimetry of Personalized Photodynamic Therapy of Tumors: A Review on Recent Trends.

Alekseeva P, Makarov V, Efendiev K, Shiryaev A, Reshetov I, Loschenov V Cancers (Basel). 2024; 16(13).

PMID: 39001546 PMC: 11240380. DOI: 10.3390/cancers16132484.


Safety and Feasibility of Photodynamic Therapy for Percutaneous Image-guided Abdominopelvic Abscess Drainage: Phase 1 Trial.

Baran T, Bass D, Christensen L, Longbine E, Favella M, Foster T Radiology. 2024; 310(3):e232667.

PMID: 38501946 PMC: 10982828. DOI: 10.1148/radiol.232667.


Application of transfer learning for rapid calibration of spatially resolved diffuse reflectance probes for extraction of tissue optical properties.

Hannan M, Baran T J Biomed Opt. 2024; 29(2):027004.

PMID: 38419753 PMC: 10901350. DOI: 10.1117/1.JBO.29.2.027004.


First in human measurements of abscess cavity optical properties and methylene blue uptake prior to photodynamic therapy by diffuse reflectance spectroscopy.

Hannan M, Sharma A, Baran T J Biomed Opt. 2024; 29(2):027002.

PMID: 38414658 PMC: 10898190. DOI: 10.1117/1.JBO.29.2.027002.


Treatment planning for photodynamic therapy of abscess cavities using patient-specific optical properties measured prior to illumination.

Li Z, Hannan M, Sharma A, Baran T Phys Med Biol. 2024; 69(5).

PMID: 38316055 PMC: 10900070. DOI: 10.1088/1361-6560/ad2635.


References
1.
Quon H, Grossman C, Finlay J, Zhu T, Clemmens C, Malloy K . Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma. Photodiagnosis Photodyn Ther. 2011; 8(2):75-85. PMC: 3598575. DOI: 10.1016/j.pdpdt.2011.01.001. View

2.
Altschuler M, Zhu T, Li J, Hahn S . Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. Med Phys. 2006; 32(12):3524-36. PMC: 4467800. DOI: 10.1118/1.2107047. View

3.
Lyon J, Pedroso e Silva Azevedo C, Moreira L, Jose de Lima C, de Resende M . Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia. 2011; 172(4):293-7. DOI: 10.1007/s11046-011-9434-6. View

4.
Cieplik F, Deng D, Crielaard W, Buchalla W, Hellwig E, Al-Ahmad A . Antimicrobial photodynamic therapy - what we know and what we don't. Crit Rev Microbiol. 2018; 44(5):571-589. DOI: 10.1080/1040841X.2018.1467876. View

5.
Penjweini R, Liu B, Kim M, Zhu T . Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling. J Biomed Opt. 2016; 20(12):128003. PMC: 4698734. DOI: 10.1117/1.JBO.20.12.128003. View